Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
128 hedge funds and large institutions have $265M invested in Aratana Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 17 closing their positions.
165% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 17
100% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 21
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
38% more capital invested
Capital invested by funds: $191M → $265M (+$73.5M)
28% more funds holding
Funds holding: 100 → 128 (+28)
18% less call options, than puts
Call options by funds: $178K | Put options by funds: $218K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$9.99M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$4.91M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$2.37M |
| 4 |
D.E. Shaw & Co
New York
|
+$2.28M |
| 5 |
Millennium Management
New York
|
+$2.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$13.6M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$9.53M |
| 3 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$7.21M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.9M |
| 5 |
BC
Broadfin Capital
New York
|
-$2.85M |
PETX Hedge Fund Activity: Q3 2016 in Review
128 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q3 2016, worth a combined $265M — up 38% from $191M a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new PETX positions and 17 closed out — a net gain of 28 holders — while 42 added to existing stakes and 21 trimmed.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $9.99M. The largest seller was Jennison Associates, cutting an estimated $13.6M.
- 128 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q3 2016, up from 100 in Q2 2016.
- Funds reported $265M of Aratana Therapeutics, Inc. stock for Q3 2016, up 38% quarter-over-quarter.
- 45 funds opened new Aratana Therapeutics, Inc. positions in Q3 2016 and 17 closed out, a net change of +28 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q3 2016 was Acadian Asset Management, an estimated $9.99M added.
- The largest Aratana Therapeutics, Inc. seller in Q3 2016 was Jennison Associates, an estimated $13.6M sold.
Based on aggregated 13F filings for Q3 2016.